Consolidated Figures in USD Millions.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Total Revenue | - | 0.11 | 0.21 | 1.81 | 2.65 |
| Operating Revenue | - | 0.11 | 0.21 | 1.81 | 2.65 |
| Cost Of Revenue | - | 1.15 | 1.73 | 1.89 | 18.03 |
| Gross Profit | - | -1.04 | -1.52 | -0.08 | -15.38 |
| Operating Expense | - | 19.91 | 17.74 | 38.21 | 97.39 |
| Research And Development | - | 13.57 | 9.95 | 24.26 | 45.27 |
| Selling General And Administration | - | 4.31 | 5.22 | 10.67 | 40.02 |
| Total Expenses | - | 21.06 | 19.47 | 40.10 | 115.42 |
| Operating Income | - | -20.95 | -19.26 | -38.29 | -112.77 |
| Total Operating Income As Reported | - | -20.95 | -20.73 | -38.29 | -112.77 |
| EBITDA | - | -20.83 | -17.39 | -36.92 | -96.80 |
| Normalized EBITDA | - | -20.56 | -14.10 | -36.70 | -97.19 |
| EBIT | - | -21.22 | -19.26 | -37.23 | -105.01 |
| Interest Income | - | - | - | 1.28 | 7.27 |
| Interest Expense | - | 0.64 | 2.26 | 1.96 | 0 |
| Net Interest Income | - | -0.64 | -2.26 | -0.68 | 7.27 |
| Other Non Operating Income Expenses | - | - | - | - | 0.09 |
| Other Income Expense | - | -0.27 | -3.29 | -0.22 | 0.48 |
| Interest Income Non Operating | - | - | - | 1.28 | 7.27 |
| Interest Expense Non Operating | - | 0.64 | 2.26 | 1.96 | 0 |
| Net Non Operating Interest Income Expense | - | -0.64 | -2.26 | -0.68 | 7.27 |
| Pretax Income | - | -21.86 | -24.81 | -39.19 | -105.02 |
| Tax Provision | - | 0 | 0 | 0 | -3.66 |
| Tax Rate For Calcs | - | 0 | 0 | 0 | 0 |
| Tax Effect Of Unusual Items | - | 0 | 0 | 0 | 0.01 |
| Net Income Continuous Operations | - | -21.86 | -24.81 | -39.19 | -101.36 |
| Net Income From Continuing And Discontinued Operation | - | -21.86 | -24.81 | -39.19 | -101.36 |
| Net Income From Continuing Operation Net Minority Interest | - | -21.86 | -24.81 | -39.19 | -101.36 |
| Net Income | - | -21.86 | -24.81 | -39.19 | -101.36 |
| Net Income Common Stockholders | - | -21.86 | -24.81 | -39.19 | -101.36 |
| Net Income Including Noncontrolling Interests | - | -21.86 | -24.81 | -39.19 | -101.36 |
| Normalized Income | - | -21.59 | -21.52 | -38.97 | -101.74 |
| Diluted NI Availto Com Stockholders | - | -21.86 | -24.81 | -39.19 | -101.36 |
| Basic Average Shares | 24.72 | 36.94 | 36.94 | 36.66 | - |
| Diluted Average Shares | 24.72 | 36.94 | 36.94 | 36.66 | - |
| Reconciled Depreciation | - | 0.39 | 1.86 | 0.31 | 8.21 |
| Reconciled Cost Of Revenue | - | 1.15 | 1.73 | 1.89 | 18.03 |
| Total Unusual Items | - | -0.27 | -3.29 | -0.22 | 0.39 |
| Total Unusual Items Excluding Goodwill | - | -0.27 | -3.29 | -0.22 | 0.39 |
| Special Income Charges | - | 0 | -1.47 | 0 | - |
| Impairment Of Capital Assets | - | 0 | 1.47 | 0 | - |
| Gain On Sale Of Security | - | -0.27 | -1.82 | -0.22 | 0.39 |
| General And Administrative Expense | - | 3.79 | 4.62 | 10.09 | 37.12 |
| Other Gand A | - | 3.79 | 4.62 | 10.09 | 37.12 |
| Total Other Finance Cost | - | - | 2.26 | 0.68 | - |
| Other Operating Expenses | - | 2.04 | 2.56 | 3.29 | 12.10 |
| Selling And Marketing Expense | - | 0.53 | 0.61 | 0.58 | 2.90 |
